Nahila Justo

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF INFECTION. 2025;90(3):106432
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study
Quint JK; Dube S; Carty L; Yokota R; Bell S; Turtle L; Lu Y; Evans K; Justo N; Harley M; Peters J; Talarico C; Mcnulty R; Goios A; Taylor S; Evans RA
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2025;26(1):35-48
Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden
Sejersen T; Graham S; Ekstrom A-B; Kroksmark A-K; Kwiatkowska M; Ganz ML; Justo N; Gertow K; Simpson A
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;35:100747
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
Evans RA; Dube S; Lu Y; Yates M; Arnetorp S; Barnes E; Bell S; Carty L; Evans K; Graham S; Justo N; Moss P; Venkatesan S; Yokota R; Ferreira C; McNulty R; Taylor S; Quint JK
Article: BMC HEALTH SERVICES RESEARCH. 2023;23(1):1340
Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain
Escobar C; Palacios B; Gonzalez V; Gutierrez M; Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernandez I; Hunt PR; Delgado JF
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2023;10(Supplement_2):ofad500.468
398. Increased Risk of Severe COVID-19 Outcomes Across all Groups of Individuals with Hematological Malignancies, Solid Tumors, and Solid Organ Transplants Compared with the General Population: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
McNulty R; Dube S; Lu Y; Graham S; Arnetorp S; Justo N; Yokota R; Evans K; Venkatesan S; Yates M; Taylor S; Quint J; Evans RA
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2023;10(Supplement_2):ofad500.069
1096. Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England
Dube S; Lu Y; McNulty R; Graham S; Arnetorp S; Justo N; Yokota R; Evans K; Venkatesan S; Yates M; Taylor S; Quint J; Evans RA
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2023;10(Supplement_2):ofad500.068
1095. Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
Dube S; Lu Y; McNulty R; Graham S; Arnetorp S; Justo N; Yokota R; Evans K; Venkatesan S; Yates M; Taylor S; Quint J; Evans RA
Article: CLINICAL DRUG INVESTIGATION. 2023;43(7):529-540
Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden
Justo N; Wilking N; Jonsson L
Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(6):2410
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction
Escobar C; Palacios B; Gonzalez V; Gutierrez M; Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernandez I; Hunt PR; Delgado JF
Journal article: VALUE IN HEALTH. 2022;25(12):s119
EE330 Productivity Losses Associated with Spinal Muscular Atrophy (SMA) in Adult Patients in Sweden Not Treated With Disease Modifying Therapies: A Population-Based Study
Simpson A; Gertow K; Sejersen T; Ekström; Kroksmark A; Graham S; Justo N; Kwiatkowska M; Ganz M; Virtanen O; Ramagopalan S
Article: BMC HEALTH SERVICES RESEARCH. 2022;22(1):1241
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
Escobar C; Palacios B; Varela L; Gutierrez M; Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernandez I; Hunt PR; Delgado JF
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(17):5199
Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain
Escobar C; Palacios B; Varela L; Gutierrez M; Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernandez I; Hunt PR; Delgado JF
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022;79(9):454
PREVALENCE AND CHARACTERISTICS OF HEART FAILURE WITH PRESERVED, MILDLY REDUCED, AND REDUCED EJECTION FRACTION IN SPAIN: A RETROSPECTIVE COHORT STUDY USING BIGPAC DATABASE
Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernandez I; Varela L; Palacios B; Hunt P; Delgado JF
Article: PLOS ONE. 2020;15(5):e0232669
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?
Justo N; Nilsson J; Korytowsky B; Dalen J; Madison T; McGuire A
Article: EUROPEAN JOURNAL OF CANCER CARE. 2020;29(1):e13171
Comorbidities and relevant outcomes, commonly associated with cancer, of patients newly diagnosed with advanced non-small-cell lung cancer in Sweden
Linden S; Redig J; Hernaez AB; Nilsson J; Bartels DB; Justo N
Article: EUROPEAN RADIOLOGY. 2016;26(11):4121-4130
Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial
Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim M-J; Rinde H; Jonas E
Article: EUROPEAN JOURNAL OF CANCER CARE. 2016;25(3):466-477
Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study
Jonsson L; Justo N; Musayev A; Krishna A; Burke T; Pellissier J; Judson I; Staddon A; Blay JY
Article: EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2015;15(4):599-605
End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes?
McGuire A; Drummond M; Martin M; Justo N
Article: ANNALS OF ONCOLOGY. 2012;23(10):2763-2770
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study
Leahy M; Garcia del Muro X; Reichardt P; Judson I; Staddon A; Verweij J; Baffoe-Bonnie A; Jonsson L; Musayev A; Justo N; Burke T; Blay JY

Alla övriga publikationer

Corrigendum: LANCET REGIONAL HEALTH-EUROPE. 2024;44:101008
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].
Evans RA; Dube S; Lu Y; Yates M; Arnetorp S; Barnes E; Bell S; Carty L; Evans K; Graham S; Justo N; Moss P; Venkatesan S; Yokota R; Ferreira C; McNulty R; Taylor S; Quint JK
Meeting abstract: AGE AND AGEING. 2024;53:afad246.077
Risk of severe COVID-19 increases with the number of comorbidities in fully vaccinated individuals aged ≥65: results from INFORM
Dube S; McNulty R; Arnetorp S; Yokota R; Carty L; Taylor S; Peters J; Justo N; Lu Y; Evans K; Yates M; Nguyen H; Olson V; Quint J; Evans R
Conference publication: VALUE IN HEALTH. 2022;25(12):S119
PRODUCTIVITY LOSSES ASSOCIATED WITH SPINAL MUSCULAR ATROPHY (SMA) IN ADULT PATIENTS IN SWEDEN NOT TREATED WITH DISEASE MODIFYING THERAPIES: A POPULATION-BASED STUDY
Simpson A; Gertow K; Sejersen T; Ekstrom AB; Kroksman AK; Graham S; Justo N; Kwiatkowska M; Ganz M; Virtanen O; Ramagopalan S
Preprint: RESEARCH SQUARE. 2022
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
Escobar C; Palacios B; Varela L; Gutiérrez M; Duong M; Chen H; Justo N; Cid-Ruzafa J; Hernández I; Hunt P; Delgado JF
Doctoral thesis: 2022
Real-world outcomes in oncology : assessing the value of rewardable innovation
Justo N
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:302
How different regulatory systems recognize and reward pharmaceutical innovation - a comparative analysis of intelectual property (IP) protection, marketing authorization and pricing/reimbursement systems with a focus on oncology
Justo N; Jonsson L; Wilking N
Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28(7):899-905
Identification and mapping of worldwide sources of generic real-world data
Wang X; Lahoz R; Jawla S; Przybysz R; Kahler KH; Burdukova L; Venkata SK; Nassim M; Jalapu A; Justo N
Review: VALUE IN HEALTH. 2019;22(6):739-749
Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America
Justo N; Espinoza MA; Ratto B; Nicholson M; Rosselli D; Ovcinnikova O; Marti SG; Ferraz MB; Langsam M; Drummond MF
Review: BMJ OPEN. 2019;9(5):e027456
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
Luttropp K; Dozier M; Justo N; Cornillie F; Kachroo S; Govoni M; Salomonsson S; Black CM; Khalifa A
Meeting abstract: VALUE IN HEALTH. 2018;21:S439
REAL WORLD TREATMENT PERSISTANCE OF GOLIMUMAB IN THE MANAGEMENT OF IMMUNE-MEDIATED RHEUMATIC DISEASES (IMRDS) IN EUROPE: A SYSTEMATIC LITERATURE REVIEW (SLR)
Justo N; Black C; Dozier M; Lutropp K; Kachroo S; Govoni M; Salomonsson S; Khalifa A
Meeting abstract: VALUE IN HEALTH. 2018;21:S199
INCLUSION OF QUANTITATIVE PREFERENCE DATA TO UNDERSTAND TREATMENT PREFERENCE IN HTA APPLICATIONS IN THE UK
Lewis HB; Latibeaudiere D; Janssen E; Justo N
Meeting abstract: VALUE IN HEALTH. 2017;20(9):A413
IMPACT OF DIFFERENT BASELINE DEFINITIONS ON THE INCIDENCE OF RELEVANT OUTCOMES ASSOCIATED WITH CANCER FOLLOWING AN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) DIAGNOSIS
Linden S; Hernaez BAM; Redig J; Nilsson J; Justo N
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2017;12(1):S471
Baseline Demographics and Comorbidities of Patients with Advanced NSCLC Compared to the General Population from Two Regions in Sweden
Linden S; Hernaez AB; Reding J; Nilsson J; Justo N; Montonen J; Verpillat P
Meeting abstract: VALUE IN HEALTH. 2016;19(7):A710
BASELINE CHARACTERISTICS AND SURVIVAL OF PATIENTS DIAGNOSED WITH ADVANCED NSCLC IN SWEDEN BETWEEN 2006 AND 2013, MATCHED (1:4) TO A COMPARISON COHORT FROM THE GENERAL POPULATION
Linden S; Hernaez BAM; Redig J; Justo N; Nilsson J; Montonen J; Verpillat P
Meeting abstract: JOURNAL OF THORACIC ONCOLOGY. 2016;11(11):S316-S317
Have We Shifted the Therapeutic Innovation Frontier? A US Assessment of Advanced Non-Small Cell Lung Cancer (advNSCLC)
Korytowsky B; Justo N; Nilsson J; Madison T; Dalen J; McGuire A
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2016;25:392
Worldwide Mapping of Generic Sources of Real-World Data: A Systematic Review
Wang X; Lahoz R; Burdukova L; Kahler K; Nassim M; Venkata SK; Jawla S; Kandhare A; Jalapu A; Justo N
Conference publication: VALUE IN HEALTH. 2016;19(3):A167
VALUE OF INNOVATION IN ONCOLOGY TREATMENTS FOR PATIENTS IN SWEDEN WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Justo N; Nilsson J; Korytowsky B; Chehab N; Stanford A; Mcguire A
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:49
Systematic assessment of heart failure data sources across 120 countries: analysis of their suitability for real-world evidence research
Castelo-Branco A; Lecomte P; Corda S; Lahoz R; Justo N; Calado F
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2015;10(9):S272
Value of Innovation in Systemic Therapy for US Patients with Advanced/Metastatic NSCLC
Nilsson J; Justo N; Korytowsky B; Chehab N; Stanford A; Mcguire A
Review: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2013;23(5):823-832
Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review
Kim K; Hernlund E; Hernadi Z; Revesz J; Pete I; Szantho A; Bodnar L; Madry R; Timorek-Lemieszczuk A; Bozanovic T; Vasovic S; Tomasevic Z; Zivaljevic M; Pazin V; Minarik T; Garanova H; Helpianska L; Justo N
Review: ONCOLOGIST. 2013;18(3):248-256
A Review of Breast Cancer Care and Outcomes in Latin America
Justo N; Wilking N; Jonsson B; Luciani S; Cazap E
Conference publication: VALUE IN HEALTH. 2012;15(7):A417-A418
TREATMENT PATTERNS, HEALTH CARE UTILIZATION, AND COSTS OF OVARIAN CANCER IN CENTRAL AND EASTERN EUROPE USING A DELPHI PANEL BASED ON A RETROSPECTIVE CHART REVIEW
Kim K; Hernlund E; Justo N; Hernadi Z; Pete I; Revesz J; Szantho A; Bodnar L; Madry R; Timorek-Lemieszczuk A; Bozanovic T; Vasovic S; Tomasevic Z; Zivaljevic M; Pazin V; Minarik T; Garanova H; Helpianska L
Meeting abstract: CANCER RESEARCH. 2011;71:p1-08-25-p1-08-25
Breast Cancer Burden, Risks and Outcomes in Latin America.
Justo NA; Wilking NE; Jonsson B
Meeting abstract: VALUE IN HEALTH. 2011;14(7):A317
COST OFFSETS AND GAINS IN HEALTH EFFECTS IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH LAQUINIMOD: AN ANALYSIS BASED ON THE ALLEGRO TRIAL
Ekman M; White RE; Buck PE; Justo N; Lindgren P
Meeting abstract: VALUE IN HEALTH. 2011;14(7):A549
A REVIEW OF BREAST CANCER (BC) CARE AND OUTCOMES IN LATIN AMERICA & CARIBBEAN (LAC)
Justo N; Wilking N; Jonsson B
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(27):202
Breast cancer (BC) care and outcomes in Latin America and the Caribbean (LAC).
Justo N; Wilking NE; Jonsson B
Meeting abstract: VALUE IN HEALTH. 2008;11(6):A423-A424
COST OF INSOMNIA IN PATIENTS OVER 54YEARS IN SWEDEN
Justo N; Jonsson L; Ekman M; Berg J
Visa fler

Anställningar

Anknuten till Forskning, Neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2024-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2022

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI